BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 16, 2007
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Neurotune AG

Zurich, Switzerland

Technology: Neurotrypsin inhibitors

Disease focus: Sarcopenia

Clinical status: Preclinical

Founded: 2005 by...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >